StreetInsider.com News Articles

TopGum Advances Longevity with Gummies for Cognition and Vision

Wed, 22 Jul 2026 07:00:00 -0400

TopGum's advanced collection of delicious gummies supports the brain-eye axis with high precision dosing and no added sugar

TEL AVIV, Israel, July 22, 2026 /PRNewswire/ -- Gummy supplements specialist TopGum Industries, Ltd. (TASE: TPGM), unveils a new collection of gummies addressing two leading themes in the longevity category. The line includes five functional gummy compositions designed to support cognition and eye health.

TopGum Advances Longevity with Gummies for Cognition and Vision

Wed, 22 Jul 2026 07:00:00 -0400

TopGum's advanced collection of delicious gummies supports the brain-eye axis with high precision dosing and no added sugar

TopGum Advances Longevity with Gummies for Cognition and Vision

Wed, 22 Jul 2026 07:00:00 -0400

TopGum's advanced collection of delicious gummies supports the brain-eye axis with high precision dosing and no added sugar

TopGum Advances Longevity with Gummies for Cognition and Vision

Wed, 22 Jul 2026 07:00:00 -0400

TopGum's advanced collection of delicious gummies supports the brain-eye axis with high precision dosing and no added sugar

TopGum Accelerates Growth: H2 2026 Revenue to Reflect an Annualized Run Rate Exceeding $145 Million

Mon, 13 Jul 2026 08:39:00 -0400

Strategic North American Customer, a High-Growth Emerging Brand, Plans Q4 2026 Costco Launch in the U.S. of a Product Exclusively Supplied by TopGum

TopGum expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million, more than 20% above the approximately $120 million annualized run rate reflected in the second half of 2025 and reported earlier this year.
Growth is driven primarily by expanding business with existing strategic customers and high-growth emerging brands in North America.
A strategic North American customer plans to launch a product

TopGum Accelerates Growth: H2 2026 Revenue to Reflect an Annualized Run Rate Exceeding $145 Million

Mon, 13 Jul 2026 08:39:00 -0400

Strategic North American Customer, a High-Growth Emerging Brand, Plans Q4 2026 Costco Launch in the U.S. of a Product Exclusively Supplied by TopGum
TopGum expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million, more than 20% above the approximately $120 million annualized run rate reflected in the second half of 2025 and reported earlier this year.
Growth is driven primarily by expanding business with existing strategic customers and high-growth emerging brands in North America.
A strategic North American customer plans to launch a product

TopGum Accelerates Growth: H2 2026 Revenue to Reflect an Annualized Run Rate Exceeding $145 Million

Mon, 13 Jul 2026 08:39:00 -0400

Strategic North American Customer, a High-Growth Emerging Brand, Plans Q4 2026 Costco Launch in the U.S. of a Product Exclusively Supplied by TopGum
TopGum expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million, more than 20% above the approximately $120 million annualized run rate reflected in the second half of 2025 and reported earlier this year.
Growth is driven primarily by expanding business with existing strategic customers and high-growth emerging brands in North America.
A strategic North American customer plans to launch a product

TopGum Accelerates Growth: H2 2026 Revenue to Reflect an Annualized Run Rate Exceeding $145 Million

Mon, 13 Jul 2026 08:39:00 -0400

Strategic North American Customer, a High-Growth Emerging Brand, Plans Q4 2026 Costco Launch in the U.S. of a Product Exclusively Supplied by TopGum
TopGum expects revenue in the second half of 2026 to reflect an annualized run rate of more than $145 million, more than 20% above the approximately $120 million annualized run rate reflected in the second half of 2025 and reported earlier this year.
Growth is driven primarily by expanding business with existing strategic customers and high-growth emerging brands in North America.
A strategic North American customer plans to launch a product

TopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record Quarter

Tue, 26 May 2026 08:28:00 -0400

Q1 2026 Revenues Grew by 85% to $31.9 Million and Adjusted EBITDA Surged by 112%
Revenues surged by 85% to $31.9 million compared to the same quarter last year - a ninth consecutive record quarter compared to the corresponding quarter
Dietary supplements segment revenues, which now account for about 81% of total Group revenues, grew to $25.8 million, a triple-digit increase of approximately 162%
Order backlog for the next 4-5 months in the dietary supplements sector reached a record high of approximately $52 million
Despite the challenges during the quarter, Adjusted EBITDA surged by 112% to $5.3 million, representing 17% of revenues (compared

TopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record Quarter

Tue, 26 May 2026 08:28:00 -0400

Q1 2026 Revenues Grew by 85% to $31.9 Million and Adjusted EBITDA Surged by 112%
Revenues surged by 85% to $31.9 million compared to the same quarter last year - a ninth consecutive record quarter compared to the corresponding quarter
Dietary supplements segment revenues, which now account for about 81% of total Group revenues, grew to $25.8 million, a triple-digit increase of approximately 162%
Order backlog for the next 4-5 months in the dietary supplements sector reached a record high of approximately $52 million
Despite the challenges during the quarter, Adjusted EBITDA surged by 112% to $5.3 million, representing 17% of revenues (compared

TopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record Quarter

Tue, 26 May 2026 08:28:00 -0400

Q1 2026 Revenues Grew by 85% to $31.9 Million and Adjusted EBITDA Surged by 112%
Revenues surged by 85% to $31.9 million compared to the same quarter last year - a ninth consecutive record quarter compared to the corresponding quarter
Dietary supplements segment revenues, which now account for about 81% of total Group revenues, grew to $25.8 million, a triple-digit increase of approximately 162%
Order backlog for the next 4-5 months in the dietary supplements sector reached a record high of approximately $52 million
Despite the challenges during the quarter, Adjusted EBITDA surged by 112% to $5.3 million, representing 17% of revenues (compared

TopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record Quarter

Tue, 26 May 2026 08:28:00 -0400

Q1 2026 Revenues Grew by 85% to $31.9 Million and Adjusted EBITDA Surged by 112%
Revenues surged by 85% to $31.9 million compared to the same quarter last year - a ninth consecutive record quarter compared to the corresponding quarter
Dietary supplements segment revenues, which now account for about 81% of total Group revenues, grew to $25.8 million, a triple-digit increase of approximately 162%
Order backlog for the next 4-5 months in the dietary supplements sector reached a record high of approximately $52 million
Despite the challenges during the quarter, Adjusted EBITDA surged by 112% to $5.3 million, representing 17% of revenues (compared

TopGum completes $35M acquisition of PL Developments

Tue, 05 May 2026 07:00:57 -0400

TopGum Industries Ltd. (TASE: TPGM) has completed its acquisition of P&L Developments LLC's U.S. gummy manufacturing operations for up to $35 million, the company announced May 5.

The transaction includes $10 million in cash at closing, 1.89 million shares valued at approximately $8 million, and up to 4.02 million additional shares worth up to $17 million contingent on achieving commercial and regulatory milestones. If all milestones are met, P&L Development will hold approximately 4% of TopGum's equity.

The acquisition gives TopGum a U.S.-based manufacturing facility built to FDA pharmaceutical standards, capable of producing both pharmaceutical gummies and dietary supplements. The companies have

TopGum completes $35M acquisition of PL Developments

Tue, 05 May 2026 07:00:57 -0400

TopGum Industries Ltd. (TASE: TPGM) has completed its acquisition of P&L Developments LLC's U.S. gummy manufacturing operations for up to $35 million, the company announced May 5.

The transaction includes $10 million in cash at closing, 1.89 million shares valued at approximately $8 million, and up to 4.02 million additional shares worth up to $17 million contingent on achieving commercial and regulatory milestones. If all milestones are met, P&L Development will hold approximately 4% of TopGum's equity.

The acquisition gives TopGum a U.S.-based manufacturing facility built to FDA pharmaceutical standards, capable of producing both pharmaceutical gummies and dietary supplements. The companies have

TopGum completes $35M acquisition of PL Developments

Tue, 05 May 2026 07:00:57 -0400

TopGum Industries Ltd. (TASE: TPGM) has completed its acquisition of P&L Developments LLC's U.S. gummy manufacturing operations for up to $35 million, the company announced May 5.

The transaction includes $10 million in cash at closing, 1.89 million shares valued at approximately $8 million, and up to 4.02 million additional shares worth up to $17 million contingent on achieving commercial and regulatory milestones. If all milestones are met, P&L Development will hold approximately 4% of TopGum's equity.

The acquisition gives TopGum a U.S.-based manufacturing facility built to FDA pharmaceutical standards, capable of producing both pharmaceutical gummies and dietary supplements. The companies have

TopGum completes $35M acquisition of PL Developments

Tue, 05 May 2026 07:00:57 -0400

TopGum Industries Ltd. (TASE: TPGM) has completed its acquisition of P&L Developments LLC's U.S. gummy manufacturing operations for up to $35 million, the company announced May 5.

The transaction includes $10 million in cash at closing, 1.89 million shares valued at approximately $8 million, and up to 4.02 million additional shares worth up to $17 million contingent on achieving commercial and regulatory milestones. If all milestones are met, P&L Development will hold approximately 4% of TopGum's equity.

The acquisition gives TopGum a U.S.-based manufacturing facility built to FDA pharmaceutical standards, capable of producing both pharmaceutical gummies and dietary supplements. The companies have

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million

Tue, 05 May 2026 07:00:00 -0400

TopGum deepens U.S. market presence, enters the pharmaceutical space and launches a long-term strategic commercial partnership with PL Developments
The transaction positions TopGum as a pioneer in the emerging pharmaceutical gummies market
RAMAT GAN, Israel and COPIAGUE, New York, May 5, 2026 /PRNewswire/ -- TopGum Industries Ltd. (TASE: TPGM), a global leader in gummy-format dietary supplements, and P&L Developments LLC ("PLD"), a leading U.S. OTC pharmaceuticals company developing and manufacturing healthcare products, today announced the completion of TopGum's acquisition of PLD's U.S. gummy manufacturing operations. The

Concentrated Shatavari Nutraceutical Gummy Leads TopGum's New Women's Collection

Wed, 15 Apr 2026 07:00:00 -0400

Supplement innovator launches collection of botanical gummies tailored to support women's wellness across the lifecycle
TEL AVIV, Israel, April 15, 2026 /PRNewswire/ -- Gummy supplement innovator TopGum Industries, Ltd. (TASE: TPGM) unveils its new line of gummy infusions designed specifically for women. The collection of seven formulations caters to the evolving needs of women throughout every phase of life, from teens to menopause and beyond. The wellness treats will be on display at Vitafoods Europe 2026 in Barcelona, booth #3G88.